Answers are grounded in this paper and cite their sources.
Table 1.Pharmacokinetics of imatinib when administered alone and with hypericum perforatum in 10 subjects Period Tmax, h Cmax,* g/mL Half-life,* h AUC0-ؕ,* g ؋ h/mL Clast,* g/mL Protein binding, % Imatinib 2.5 (1-4) 1.80 (0.88-2.6) 13.5 (10.8-18.1)28.9 (13.4-36.7)0.11 (0.05-0.17) 95.0 (90.3-97.7)Imatinib ϩ hypericum perforatum 2.5 (1-8) 1.28 (0.92-2.0) 10.7 (9.1-13.5)19.7 (10.7-25.0)0.05 (0.03-0.12) 95.1 (90.9-97.3)Data presented as median (range).Tmax indicates time of Cmax; Clast, imatinib concentration at 48 hours.*P Ͻ .005by paired t test on logarithmically transformed data.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: